[1] Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27, 1047-53. doi:  10.2337/diacare.27.5.1047
[2] Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population:International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia, 2003; 46, 1190-8. doi:  10.1007/s00125-003-1167-8
[3] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010; 362, 1090-101. doi:  10.1056/NEJMoa0908292
[4] Malhotra P, Kumar R, Kumari S, et al. Dysglycaemia and risk of cardiovascular disease. Lancet, 1996; 347, 1835. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_3d9410342f54d4add75a9846252716b0
[5] Bonora E, Kiechl S, Willeit J, et al. Plasma glucose within the normal range is not associated with carotid atherosclerosis:prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care, 1999; 22, 1339-46. doi:  10.2337/diacare.22.8.1339
[6] Balkau B, Bertrais S, Ducimetiere P, et al. Is there a glycemic threshold for mortality risk? Diabetes Care, 1999; 22, 696-9. doi:  10.2337/diacare.22.5.696
[7] Vollenweider P, von Eckardstein A, Widmann C. HDLs, diabetes, and metabolic syndrome. Handb Exp Pharmacol, 2015; 224, 405-21. doi:  10.1007/978-3-319-09665-0
[8] Elmadhoun WM, Noor SK, Ibrahim AA, et al. Prevalence of diabetes mellitus and its risk factors in urban communities of north Sudan:Population-based study. J Diabetes, 2016; 8, 839-46. doi:  10.1111/1753-0407.12364
[9] Zuo H, Shi Z, Hussain A. Prevalence, trends and risk factors for the diabetes epidemic in China:a systematic review and meta-analysis. Diabetes Res Clin Pract, 2014; 104, 63-72. doi:  10.1016/j.diabres.2014.01.002
[10] Chen G, Zou X, Yao J, et al. The correlation between the oral glucose tolerance test 30-minutes plasma glucose and risk factors for diabetes and cardiovascular diseases:a cross-sectional epidemiological study of diabetes in Fujian Province in the South-East of China. J Endocrinol Invest, 2011; 34, e115-20. doi:  10.1007/BF03347470
[11] Pérez CM, Soto-Salgado M, Suárez E, et al. High Prevalence of Diabetes and Prediabetes and Their Coexistence with Cardiovascular Risk Factors in a Hispanic Community. J Immigr Minor Health, 2015; 17, 1002-9. doi:  10.1007/s10903-014-0025-8
[12] Zhang D, Wang W, Li F. Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases:a meta-analysis. CMAJ, 2016; 188, E384-92. doi:  10.1503/cmaj.160050
[13] Li H, Xu T, Tong W, et al. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J, 2008; 72, 1666-73. doi:  10.1253/circj.CJ-08-0138
[14] Kim SK, Park JH, Lee JJ, et al. Smoking in elderly Koreans:prevalence and factors associated with smoking cessation. Arch Gerontol Geriatr, 2013; 56, 214-9. doi:  10.1016/j.archger.2012.08.018
[15] Chen F, Guo Z, Wu M, et al. Impact of dynamic changes of waist circumference and body mass index on type 2 diabetes mellitus risk. Chinese Journal Preventive Medicine, 2015; 49, 1092-7. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyfyx201512014
[16] Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation, 1993; 88, 2460-70. doi:  10.1161/01.CIR.88.5.2460
[17] Hansson L, Hedner T, Himmelmann A. The 1999 WHO-ISH Guidelines for the Management of Hypertension——new targets, new treatment and a comprehensive approach to total cardiovascular risk reduction. Blood Press Suppl, 1999; 1, 3-5. http://www.ncbi.nlm.nih.gov/pubmed/10401539
[18] Sitzmann FC, Eschler P. Enzymatic determination of blood glucose with a modified hexokinase method. Med Klin, 1970; 65, 1178-83. http://www.ncbi.nlm.nih.gov/pubmed/5517345
[19] Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem, 1974; 20, 470-5. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_51ee8ec14800f7e5e726416f34dbafc8
[20] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18, 499-502. https://www.ncbi.nlm.nih.gov/pubmed/4337382
[21] Chinese guidelines on prevention and treatment of dyslipidemia in adults (Revised Edition 2016). Chinese Circulation Journal, 2016; 31, 937-53. (In Chinese)
[22] Diaz BB, Sanchez JJA, de Leon AC. Resting heart rate and cardiovascular disease. Medicina Clinica, 2014; 143, 34-8. doi:  10.1016/j.medcli.2013.05.034
[23] Harati H, Hadaegh F, Tohidi M, et al. Impaired fasting glucose cutoff value of 5.6 mmol/L combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/L value:Tehran lipid and glucose study. Diabetes Res Clin Pract, 2009; 85, 90-5. doi:  10.1016/j.diabres.2009.04.006
[24] Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus:20-year prospective study in a general population. Am J Hypertens, 2009; 22, 151-5. doi:  10.1038/ajh.2008.331
[25] Wang L, Cui L, Wang Y, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes:the Kailuan prospective study. Int J Epidemiol, 2015; 44, 689-99. doi:  10.1093/ije/dyv079
[26] Grassi G, Vailati S, Bertinieri G, et al. Heart rate as marker of sympathetic activity. J Hypertens, 1998; 16, 1635-9. doi:  10.1097/00004872-199816110-00010
[27] Jamerson KA, Julius S, Gudbrandsson T, et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension, 1993; 21, 618-23. doi:  10.1161/01.HYP.21.5.618
[28] Ho JE, Larson MG, Ghorbani A, et al. Long-term Cardiovascular Risks Associated With an Elevated Heart Rate:The Framingham Heart Study. J Am Heart Assoc, 2014; 3.
[29] Piwonska A, Piotrowski W, Broda G, et al. The relationship between resting heart rate and atherosclerosis risk factors. Kardiologia Polska, 2008; 66, 1069-74. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM19006028
[30] Farah BQ, Christofaro DGD, Balagopal PB, et al. Association between resting heart rate and cardiovascular risk factors in adolescents. European Journal of Pediatrics, 2015; 174, 1621-8. doi:  10.1007/s00431-015-2580-y
[31] Jiang X, Liu X, Wu S, et al. Metabolic syndrome is associated with and predicted by resting heart rate:a cross-sectional and longitudinal study. Heart, 2015; 101, 44-9. doi:  10.1136/heartjnl-2014-305685
[32] Inoue T, Iseki K, Ohya Y. Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease. Hypertens Res, 2013; 36, 838-44. doi:  10.1038/hr.2013.98
[33] Menown IB, Davies S, Gupta S, et al. Resting heart rate and outcomes in patients with cardiovascular disease:where do we currently stand? Cardiovasc Ther, 2013; 31, 215-23. doi:  10.1111/cdr.2013.31.issue-4
[34] Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U. S. adults. Obes Res, 2003; 11, 1223-31. doi:  10.1038/oby.2003.168
[35] Huang T, Qi Q, Zheng Y, et al. Genetic Predisposition to Central Obesity and Risk of Type 2 Diabetes:Two Independent Cohort Studies. Diabetes Care, 2015; 38, 1306-11. doi:  10.2337/dc14-3084
[36] Xue H, Wang C, Li Y, et al. Incidence of type 2 diabetes and number of events attributable to abdominal obesity in China:A cohort study. J Diabetes, 2016; 8, 190-8. doi:  10.1111/1753-0407.12273
[37] Li Z, Deng ML, Tseng CH, et al. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity. Metab Syndr Relat Disord, 2013; 11, 87-91. doi:  10.1089/met.2012.0090
[38] Carlsson AC, Riserus U, Arnlov J. Hypertriglyceridemic waist phenotype is associated with decreased insulin sensitivity and incident diabetes in elderly men. Obesity (Silver Spring), 2014; 22, 526-9. doi:  10.1002/oby.20434
[39] Liang Z, Qiu QY, Wu JH, et al. Alcohol Drinking, Dyslipidemia, and Diabetes:A Population-based Prospective Cohort Study among Inner Mongolians in China. Biomed Environ Sci, 2016; 29, 555-62. http://www.ncbi.nlm.nih.gov/pubmed/27660219
[40] Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus:a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA, 1997; 278, 2069-74. doi:  10.1001/jama.1997.03550230045035